Subject Author Posted Rep. last R. [desc] Views
Achievwin 2024-06-07 15:42 2 2024-06-10 09:10 557
rezkighassani 2024-06-03 06:23 0   402
rezkighassani 2024-03-04 05:40 1 2024-03-12 17:30 1,024
Porfirio 2023-07-18 17:55 5 2024-02-29 14:08 2,341
mahendra 2013-10-24 16:10 35 2022-09-17 03:50 38,491
Helmut 2022-03-16 14:06 2 2022-03-30 10:00 2,120
joao.reis 2022-03-24 16:35 3 2022-03-24 20:03 2,456
BE-proff 2022-02-24 06:25 1 2022-03-02 18:17 1,961
mittyri 2018-06-09 22:39 8 2022-02-17 11:06 7,943
Ahikal 2021-12-24 17:41 1 2021-12-29 09:28 2,124
MGR 2007-02-02 10:10 26 2021-11-11 07:35 41,244
Helmut 2018-11-09 18:01 8 2021-10-28 14:20 8,273
Farmacevt 2021-07-30 17:31 1 2021-08-05 11:43 3,362
pharm07 2021-06-22 11:09 5 2021-06-25 02:51 2,400
Taonga Pomerai 2021-01-04 14:46 0   1,585
UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,663 registered users;
47 visitors (0 registered, 47 guests [including 6 identified bots]).
Forum time: 01:40 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5